Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.90
0.15.56%
At close: -
$1.88
-0.02-1.05%
After Hours: 5:28 PM EDT
Comments
Loading...
Allogene Therapeutics Stock Price, Quotes and Forecasts
ALLONASDAQ
Allogene Therapeutics (ALLO) Forecast
NewsEarningsAllogene Therapeutics (ALLO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Allogene Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ALLO | Benzinga
Explore Allogene Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALLO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Allogene Therapeutics (ALLO) stock?
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Who are Allogene Therapeutics (ALLO) competitors?
Other companies in Allogene Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Altimmune (NASDAQ:ALT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?
Allogene Therapeutics has a consensus price target of $13.31.
What is the current price for Allogene Therapeutics (ALLO)?
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.88 last updated March 4, 2025 at 5:28 PM EST.
Does Allogene Therapeutics (ALLO) pay a dividend?
There are no upcoming dividends for Allogene Therapeutics.
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Allogene Therapeutics (ALLO) going to split?
There is no upcoming split for Allogene Therapeutics.
What sector and industry does Allogene Therapeutics (ALLO) operate in?
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.